Molecular Testing Identifies Ultra-Late Recurrences in Lung Carcinomas: Implications for Clinical Management. Yang SR, Rekhtman N. J Thorac Oncol 2022;17:e50-e51.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang SR, Rekhtman N. Molecular Testing Identifies Ultra-Late Recurrences in Lung Carcinomas: Implications for Clinical Management. J Thorac Oncol 2022;17:e50-e51.
PMID: 35307111